Evidence map›Paper›PMID 35552454›Full record

ArticleThe oncologist2022

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma.

Kimberly M Burcher, Harper L Wilson, Elena Gavrila, Arianne Abreu, Ralph B D'Agostino, Wei Zhang, Mercedes Porosnicu

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The oncologist, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Kimberly M BurcherDepartment of Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.ORCID 0000-0001-5376-394X
Harper L WilsonDepartment of Anesthesiology & Perioperative Medicine, Medical University of South Carolina College of Medicine, Charleston, SC, USA.
Elena GavrilaWake Forest School of Medicine, Winston-Salem, Salem, VA, USA.
Arianne AbreuDepartment of Internal Medicine, LewisGale Medical Center, Salem, VA, USA.
Ralph B D'AgostinoBiostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Wei ZhangCancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Mercedes PorosnicuMedical Oncology and Hematology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Model-based Prediction of Redox-Modulated Responses to Cancer TreatmentsU01CA215848 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI FURDUI, CRISTINA MARIA, KEMP, MELISSA LAMBETH · 2017 to 2021
$3.6M
NCI NIH HHS P30 CA012197NCI NIH HHS U01 CA215848
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Head and Neck NeoplasmsBiomarkers, TumorHumansPrevalencePrognosisSquamous Cell Carcinoma of Head and NeckTumor Suppressor Protein p53Biomarkers, TumorTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID35552454
PMCPMC9256026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.